PAROLINI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 4.270
EU - Europa 2.245
AS - Asia 1.482
AF - Africa 8
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
Totale 8.021
Nazione #
US - Stati Uniti d'America 4.259
CN - Cina 1.056
PL - Polonia 743
UA - Ucraina 523
IT - Italia 256
DE - Germania 219
HK - Hong Kong 129
IN - India 122
FI - Finlandia 116
FR - Francia 116
GB - Regno Unito 111
SG - Singapore 100
IE - Irlanda 88
SE - Svezia 23
KR - Corea 22
BE - Belgio 20
VN - Vietnam 20
TR - Turchia 18
CA - Canada 11
CZ - Repubblica Ceca 10
AU - Australia 7
MU - Mauritius 7
NL - Olanda 7
EU - Europa 6
RO - Romania 4
IR - Iran 3
JP - Giappone 3
RU - Federazione Russa 3
ID - Indonesia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AR - Argentina 1
BN - Brunei Darussalam 1
BR - Brasile 1
CL - Cile 1
EE - Estonia 1
IL - Israele 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 8.021
Città #
Warsaw 743
Fairfield 640
Woodbridge 452
Shenzhen 403
Jacksonville 371
Houston 352
Ashburn 311
Chandler 296
Cambridge 277
Ann Arbor 269
Seattle 243
Wilmington 226
Princeton 152
Nanjing 151
Brescia 135
Hong Kong 127
Beijing 122
New York 101
Dearborn 87
Dublin 86
Nanchang 57
Singapore 56
Helsinki 52
Jinan 38
Changsha 35
San Diego 34
Shenyang 33
Tianjin 28
Des Moines 27
Hebei 27
Milan 27
London 24
Shanghai 22
Dong Ket 20
Seongnam 19
Brussels 17
Verona 16
Kocaeli 15
Jiaxing 14
Genova 13
Kunming 13
San Francisco 13
Hangzhou 12
Los Angeles 12
Zhengzhou 12
Ningbo 10
Taizhou 10
Toronto 10
Changchun 9
Haikou 9
Lanzhou 9
Leawood 9
Boardman 8
Brno 8
Lancaster 7
Augusta 6
Origgio 6
San Mateo 6
Washington 6
Mcallen 5
Phoenix 5
Redwood City 5
Cerreto Guidi 4
Kilburn 4
Shaoxing 4
Sydney 4
Taiyuan 4
Auburn Hills 3
Charlotte 3
Edinburgh 3
Frankfurt am Main 3
Fuzhou 3
Monmouth Junction 3
Munich 3
Pune 3
Altmannstein 2
Amsterdam 2
Ardabil 2
Brooklyn 2
Chiswick 2
Cluj-Napoca 2
Guangzhou 2
Hyderabad 2
Lappeenranta 2
Lumezzane 2
Marcheno 2
Nanning 2
New Delhi 2
Olginate 2
Olomouc 2
Orange 2
Prescot 2
Redmond 2
Rome 2
San Benedetto Po 2
Seoul 2
Surabaya 2
Tokyo 2
Waanrode 2
Acton 1
Totale 6.401
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 514
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP 287
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 282
NFKB1 regulates human NK cell maturation and effector functions 274
XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells. 242
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 239
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 151
The RAC2-PI3K axis regulates human NK cell maturation and function 151
Functional Characterization Of Natural Killer Cells In Type I Leukocyte Adhesion Deficiency 143
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 139
CTLA-4 regulates human Natural Killer cell effector functions 131
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. 130
Activin A as a Mediator of NK-Dendritic Cell Functional Interactions. 127
A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency 124
Inherited DOCK2 deficiency in patients with early-onset invasive infections 123
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 121
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 121
Effects of opioid therapy on human natural killer cells. 118
Selective cross-talk among natural cytotoxicity receptors in human natural killer cells 115
2B4 functions as a co-receptor in human NK cell activation 115
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 109
X-linked lymphoproliferative disease: the dark side of 2B4 function. 107
Cellular and molecular pathogenesis of X-linked lymphoproliferative disease. 107
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 106
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 106
Novel insights from adaptor protein 3 complex deficiency 106
Biological characterization and in vitro effects of human concentrated growth factor preparation: An innovative approach to tissue regeneration 104
Development of chicken embryos exposed to an intermittent horizontal sinusoidal 50 Hz magnetic field. 101
NK cells at the interface between innate and adaptive immunity 100
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. 100
Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome 99
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 99
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. 96
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 95
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 94
Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients 93
Innate immunity defects in Hermansky-Pudlak type 2 syndrome 90
NK cells and their receptors during viral infections. 89
GPR56 as a novel marker identifying the CD56dull CD16+ Nk cell subset both in blood stream and in inflamed peripheral tissues 88
Human natural killer cell receptors and co-receptors 87
Natural killer cell hyporesponsiveness and impaired development in a CD247-deficient patient 87
Identification of NKp80, a novel triggering molecule expressed by human NK cells 86
Pseudorabies virus US3 protein kinase protects infected cells from NK cell-mediated lysis via increased binding of the inhibitory NK cell receptor CD300a 86
The AZ158 mAb specifically reacts with p70 and p140 inhibitory NK receptors for HLA-B and HLA-A alleles 82
Identification and Molecular Characterization of NKp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells. 79
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 79
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation. 78
Function and specificity of human natural killer cell receptors. 76
The LIR-1 receptor for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles. 75
La sindrome emofagocitica: dai sintomi alle cause genetiche 71
Basement Membrane Components in Normal, Dysplastic and Neoplastic Epithelia of the Uterine Cervix 71
IL21 induces both rapid maturation of human CD34+ cell precursors towards NK cell and acquisition of surface killer Ig-like receptors 70
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 69
Linker for Activation of T cells (LAT), a novel immunohistochemical marker for T cells, NK cells, mast cells, and megakaryocytes. Evaluation in normal and pathological conditions 68
Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. 68
In vitro treatment with concentrated growth factors (CGF) and sodium orthosilicate positively affects cell renewal in three different human cell lines 68
CD59 is physically and functionally associated to Natural Citotoxicity Receptors and activates human NK cell mediated cytotoxicity. 67
P85α is an intrinsic regulator of human natural killer cell effector functions 67
Distinctive Lack of CD48 Expression in Subsets of Human Dendritic Cells Tunes Natural Killer Cell Activation 66
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells 66
[Distribution of laminin, type IV collagen and fibronectin in normal, dysplastic and neoplastic laryngeal tissue]. 66
IL-12 or IL-4 Prime Human NK Cells to Mediate Functionally Divergent Interaction with Cells or Tumors 65
Immunohistochemical localization of laminin, collagen IV and fibronectin in dysplasias and neoplasms of the cervix uteri 65
CD94 functions as a natural killer cells inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 64
Immunocytochemical localization of plasminogen activators in carcinomas in the cervix and vulva. 62
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases 61
Characterization of a new patient with STAT1 deficiency: new insights into IFNs signal transduction pathways 61
Triggering Receptors involved in Natural Killer cell mediated cytotoxicity against Choriocarcinomas cells lines 60
Inhibitory CD94 molecules identified by the Z199 monoclonal antibody recognize different HLA-class I molecules. 60
Distribuzione di laminina, collagene di tipo IV e fibronectina nel tessuto laringeo normale, displastico e neoplastico. 59
Killer cell immunoglobulin-like receptor expression delineates in situ Sezary syndrome lymphocytes 54
Lack of iNKT Cells and Defects on Differentiation of Dendritic Cells in Patients with Hermansky-Pudlak Type 2 Syndrome (HPS2) 52
LAT (Linker for activation of T cells): A novel immunohistochemical marker for T, NK, mast cells and megakaryocytes. Evaluation in normal and pathological conditions. 51
NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of Natutal Killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease 49
Impaired natural and CD16-mediated NK cell cytotoxic function in WAS and XLT patients: ability of IL-2 to correct NK cell functional defect 48
Natural killer cell impairment in ovarian clear cell carcinoma 45
Exome Sequencing Reveals a Pallidin Mutation in a Hermansky-Pudlak-Like Primary Immunodeficiency Syndrome 43
Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor κB kinase alpha (IKKα) 33
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 33
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 32
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis 22
FGF-trapping hampers cancer stem-like cells in uveal melanoma 11
Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications 6
Totale 8.204
Categoria #
all - tutte 34.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.791 0 0 96 244 130 251 206 225 145 301 81 112
2020/20211.331 31 127 28 250 54 135 46 140 187 130 153 50
2021/2022768 45 146 15 52 16 26 30 42 48 106 53 189
2022/2023787 120 7 14 93 55 216 7 88 105 7 37 38
2023/20241.022 43 10 469 30 28 131 38 44 128 4 9 88
2024/202517 13 4 0 0 0 0 0 0 0 0 0 0
Totale 8.204